Lipopolysaccharide (LPS) is a major surface component of Chlamydia trachomatis, as with all Gram-negative bacteria. The effect of C. trachomatis LPS on C. trachomatis infectivity of human epithelial cells was investigated. C. trachomatis LPS and C. trachomatis LPS antibody significantly reduced infectivity, mostly in a dose-dependent manner. As the structure of LPS in C. trachomatis is simple and consists only of lipid A and 3-deoxy-d-manno-octulosonic acid (Kdo), we investigated whether lipid A or Kdo was inhibitory to chlamydial infectivity. Polymyxin B, as a lipid A inhibitor, and Kdo considerably reduced C. trachomatis infectivity. With all the LPS inhibitors used, there was greater inhibition against serovar E than serovar LGV. These results suggest a role for LPS in chlamydial infectivity. Elucidation of how LPS acts in infectivity and identification of host-cell receptors would help in understanding pathogenicity.
AlfaM. J.,
DeGagneP.1997; Attachment of Haemophilus ducreyi to human foreskin fibroblasts involves LOS and fibronectin. Microb Pathog 22:39–46[CrossRef]
BelangerM.,
DubreuilD.,
HarelJ.,
GirardC.,
JacquesM.1990; Role of lipopolysaccharide in adherence of Actinobacillus pleuropneumoniae to porcine tracheal rings. Infect Immun 58:3523–3530
BradeH.1999; Chlamydial lipopolysaccharide. In Endotoxin in Health and Disease pp 229–242 Edited by
BradeH.,
OpalS. M.,
VogelS. N.,
MorrisonD. C.
New York: Marcel Dekker;
ByrneG. I.,
StephensR. S.,
AdaG.,
CaldwellH. D.,
SuH.,
MorrisonR. P.,
Van der PolB.,
BavoilP.other authors1993; Workshop on in vitro neutralization of Chlamydia trachomatis : summary of proceedings. J Infect Dis 168:415–420[CrossRef]
CollettB. A.,
NewhallW. J.,
JersildR. A.Jr,
JonesR. B.1989; Detection of surface-exposed epitopes on Chlamydia trachomatis by immune electron microscopy. J Gen Microbiol 135:85–94
FadelS.,
EleyA.2004; Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis -infected cells. J Med Microbiol 53:93–95[CrossRef]
HarveyH. A.,
PoratN.,
CampbellC. A.,
JenningsM.,
GibsonB. W.,
PhillipsN. J.,
ApicellaM. A.,
BlakeM. S.2000; Gonococcal lipooligosaccharide is a ligand for the asialoglycoprotein receptor on human sperm. Mol Microbiol 36:1059–1070[CrossRef]
HeineH.,
Muller-LoenniesS.,
BradeL.,
LindnerB.,
BradeH.2003; Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur J Biochem 270:440–450[CrossRef]
JeannotteM. E.,
Abul-MilhM.,
DubreuilJ. D.,
JacquesM.2003; Binding of Actinobacillus pleuropneumoniae to phosphatidylethanolamine. Infect Immun 71:4657–4663[CrossRef]
KrivanH. C.,
NilssonB.,
LingwoodC. A.,
RyuH.1991; Chlamydia trachomatis and Chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to GalNAc beta 1–4Gal beta 1–4GLC sequences-found in asialo-GM1 and asial-GM2. Biochem Biophys Res Commun 175:1082–1089[CrossRef]
KuoC.,
TakahashiN.,
SwansonA. F.,
OzekiY.,
HakomoriS.1996; An N -linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis , mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest 98:2813–2818[CrossRef]
NorkinL. C.,
WolfsonS. A.,
StuartE. S.2001; Association of caveoli with Chlamydia trachomatis inclusions at early and late stages of infection. Exp Cell Res 266:229–238[CrossRef]
ParadisS. E.,
DubreuilJ. D.,
GottschalkM.,
ArchambaultM.,
JacquesM.1999; Inhibition of adherence of Actinobacillus pleuropneumoniae to porcine respiratory tract cells by monoclonal antibodies directed against LPS and partial characterization of the LPS receptors. Curr Microbiol 39:313–320[CrossRef]
RaulstonJ. E.,
DavisC. H.,
SchmielD. H.,
MorganM. W.,
WyrickP. B.1993; Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins. J Biol Chem 268:23139–23147
RedeckeV.,
DalhoffK.,
BohnetS.,
BraunJ.,
MaassM.1998; Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 19:721–727[CrossRef]
StephensR. S.,
PoteralskiJ. M.,
OlingerL.2006; Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulphate glycosaminoglycans. Infect Immun 74:1795–1799[CrossRef]
SuH.,
WatkinsN. G.,
ZhangY. X.,
CaldwellH. D.1990; Chlamydia trachomatis –host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun 58:1017–1025
TaraktchoglouM.,
PaceyA. A.,
TurnbullJ. E.,
EleyA.2001; Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulphate. Infect Immun 69:968–976[CrossRef]
TsuberyH.,
OfekI.,
CohenS.,
EisensteinM.,
FridkinM.2002; Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Mol Pharmacol 62:1036–1042[CrossRef]
Whittum-HudsonJ. A.,
RudyD.,
GerardH.,
VoraG.,
DavisE.,
HallerP. K.,
PrattisS. M.,
HudsonA. P.,
SaltzmanW. M.,
StuartE. S.2001; The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis
. Vaccine 19:4061–4071[CrossRef]